Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer

BACKGROUND: Combined androgen blockade (cab) is a promising treatment modality for prostate cancer (pca). In the present meta-analysis, we compared the efficacy and safety of first-line cab using an antiandrogen (aa) with castration monotherapy in patients with advanced pca. METHODS: PubMed, embase,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Curr Oncol
Päätekijät: Yang, Y., Chen, R., Sun, T., Zhao, L., Liu, F., Ren, S., Wang, H., Lu, X., Gao, X., Xu, C., Sun, Y.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Multimed Inc. 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380654/
https://ncbi.nlm.nih.gov/pubmed/30853808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4203
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia